The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.

Stocker, Kurt; Hartmann, Matthias; Ley, Laura; Becker, Anna M; Holze, Friederike; Liechti, Matthias E

Stocker, Kurt; Hartmann, Matthias; Ley, Laura; Becker, Anna M; Holze, Friederike; Liechti, Matthias E.

Afiliação

Stocker K; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, and University of Basel, Basel, Switzerland.
Hartmann M; Chair of Cognitive Science, Department of Humanities, Social and Political Sciences, ETH Swiss Federal Institute of Technology Zurich, Zurich, Switzerland.
Ley L; Department of Psychology, University of Zurich, Zurich, Switzerland.
Becker AM; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.
Holze F; Faculty of Psychology, UniDistance Suisse, Brig, Switzerland.
Liechti ME; Psychopharmacology Research, Division of Clinical Pharmacology & Toxicology, Department of Clinical Research, University Hospital Basel, and University of Basel, Basel, Switzerland.

J Psychopharmacol ; 38(1): 80-100, 2024 Jan.

Article em En | MEDLINE | ID: mdl-37905369

Assuntos

Alucinógenos; Humanos; Psilocibina; Reprodutibilidade dos Testes; Misticismo; Estado de Consciência; Dietilamida do Ácido Lisérgico

Palavras-chave

LSD; Psychedelic experience; mystical experience; psilocybin; psychometrics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alucinógenos Limite: Humans Idioma: En Revista: J Psychopharmacol Assunto da revista: PSICOFARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google